| Jessica Lynn Alcon-romero, CNP | |
|
1010 Spruce St, Pmg Espanola, Espanola, NM 87532-2724 | |
| (505) 367-0365 | |
| (505) 367-0362 |
| Full Name | Jessica Lynn Alcon-romero |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1010 Spruce St, Espanola, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710165881 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R62161 (New Mexico) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | CNP-02437 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Daiya Healthcare Pllc | 6002158615 | 108 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
| Entity Name | Presbyterian Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871505032 PECOS PAC ID: 2062324684 Enrollment ID: O20031103000414 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
| Entity Name | Taos Health Systems Inc Holy Cross Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194751958 PECOS PAC ID: 8224937412 Enrollment ID: O20040107000398 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
| Entity Name | Taos Professional Services,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891070777 PECOS PAC ID: 6507019924 Enrollment ID: O20130116000178 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
| Entity Name | Minuteclinic Diagnostic Of New Mexico, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740601012 PECOS PAC ID: 7517280266 Enrollment ID: O20150105000196 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
| Entity Name | Newmexidoc Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316358989 PECOS PAC ID: 6204150659 Enrollment ID: O20150113002432 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
| Entity Name | Daiya Healthcare Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477027381 PECOS PAC ID: 6002158615 Enrollment ID: O20200903001256 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Lynn Alcon-romero, CNP Po Box 26666, Presbyterian Healthcare Services, Albuquerque, NM 87125-6666 Ph: (505) 923-6770 | Jessica Lynn Alcon-romero, CNP 1010 Spruce St, Pmg Espanola, Espanola, NM 87532-2724 Ph: (505) 367-0365 |
News Archive
Researchers in the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist and Texas Children's Hospital have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
What can you see in this picture (next to the article)? Say what comes to your mind immediately!
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 8 days ago
Bailey Pearson, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1010 Spruce St, Espanola, NM 87532 Phone: 505-367-0340 | |
Mr. Stephen Lynn Mason, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1200 N Paseo De Onate, Espanola, NM 87532 Phone: 505-747-0081 | |
Dr. Keith Bryan Haynie, DNP, RN, CFNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 206 S Coronado Ave, Espanola, NM 87532 Phone: 860-788-6404 Fax: 860-398-6441 | |
Kimberly Allen, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1010 Spruce St, Espanola, NM 87532 Phone: 505-753-7111 | |
Jonathan C Peachey, CFNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1010 Spruce St, Espanola Hospital, Espanola, NM 87532 Phone: 505-753-7111 Fax: 505-753-4438 | |
Leticia A Luketich Martinez, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2010 Industrial Park Rd, Espanola, NM 87532 Phone: 505-753-7218 Fax: 505-747-7396 | |
Tiffin Marie Zellers, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1308 N Orchard, Espanola, NM 87532 Phone: 505-927-0157 Fax: 855-928-4040 |